The owners of aland Health Holding, a China-based global nutritional supplements producer, are seeking buyers for their controlling stake in a deal expected to value the company at more than $1.5bn, according to Reuters sources.

Founder and chairman Chang Liang owns around 60% of aland, with the remainder held by Affinity Equity Partners, Goldman Sachs Growth Equity, and Henderson Investment Corp. The company is on track to generate about $150m in EBITDA this year.

The potential sale has already attracted preliminary interest from both strategic investors and private equity firms, drawn to aland’s significant US footprint through subsidiary International Vitamin Corporation (IVC). IVC operates several US manufacturing sites, including major facilities in South Carolina acquired from GNC in 2019.

Founded in 1998, aland has grown into a multinational business with over 5,000 employees, 11 manufacturing sites, and four R&D centres across Asia, North America, and Europe. The company produces a wide range of branded and private-label supplements, OTC products, and vitamins for major retailers such as Walmart and Costco.

The sale process is still in its early stages with no fixed timetable for bids. The transaction comes as the $485.6bn global nutritional supplements market is projected to expand to $704.3bn by 2030, fuelled by surging consumer demand for wellness products.

If you think we missed any important news, please do not hesitate to contact us at [email protected].

Can`t stop reading? Read more.